Clinical trials for rectal cancer

48 currently recruiting clinical trials
Rectal cancer

Phase 2 Colon cancer Rectal cancer
#NCT06152523
Adenocarcinoma Locally Advanced Metastatic MSI/dMMR Systemic Treatment-Naive Chemotherapy
Immunotherapy Immunotherapy
Hôpital Saint Antoine AP-HP (Paris)
Assistance Publique - Hôpitaux de Paris
Phase 2 Colon cancer Rectal cancer
#NCT05706129
Locally Advanced Metastatic Chemotherapy Targeted therapy
Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Universitaire de Nantes (Nantes), IUCT Oncopôle (Toulouse), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 2 Colon cancer Rectal cancer
#NCT04976634
Locally Advanced Metastatic MSS Chemotherapy
MSI/dMMR Immunotherapy Targeted therapy Systemic Treatment-Naive Immunotherapy Targeted therapy
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut du cancer de Montpellier (Montpellier), Institut Sainte Catherine (Avignon), Centre Eugene Marquis (Rennes), Centre Hospitalier Universitaire de Besançon (Besançon)
Merck KGaA
Phase 2 Colon cancer Rectal cancer
#NCT05310643
Adenocarcinoma Metastatic MSI/dMMR Chemotherapy Targeted therapy
MSS
Hôpital Saint Antoine AP-HP (Paris), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2 Colon cancer Rectal cancer
#NCT04262687
Metastatic MSS Systemic Treatment-Naive
MSI/dMMR Immunotherapy Immunotherapy
Hôpital Privé Arnault Tzanck Mougins Sophia Antipolis (Mougins), Hôpital Européen de Marseille (Marseille), Centre hospitalier Intercommunal Mont-de-Marsan - Pays des Sources (Mont-de-Marsan), CHU de Rennes - Hôpital Pontchaillou (Rennes), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire) (and 53 more...)
Fédération Francophone de Cancérologie Digestive
Phase 2 Colon cancer Rectal cancer
#NCT03175224
Locally Advanced Metastatic MET
BRAF RET NTRK-1/2/3 KRAS G12C KRAS non G12C Systemic Treatment-Naive Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2 Colon cancer Rectal cancer Anal cancer
#NCT04954820
Neuroendocrine tumor
Systemic Treatment-Naive Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 22 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer
#NCT05751798
MSI/dMMR PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%)
Systemic Treatment-Naive Immunotherapy Systemic Treatment-Naive Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer
#NCT05384626
Locally Advanced Metastatic Metastatic Castration-resistant Other mutation
BRAF MET HER2 RET NTRK-1/2/3 KRAS G12C KRAS non G12C BRCA 1/2 AKT PIK3CA PALB2 ESR FGFR PTEN MSI/dMMR ATM CDK12 HOXB13 CHEK 1/2 NRAS Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2 Colon cancer Rectal cancer
#NCT03475953
Locally Advanced Metastatic Immunotherapy Chemotherapy Targeted therapy Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris), Gustave Roussy (Villejuif) (and 2 more...)
Institut Bergonié